A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Design Standards as Strategic Assets
Rising Violence is Exposing Gaps in Hospital Security
Murray County Medical Center Reports Data Security Incident
Probiotic Cleaning: A Complementary Strategy for Safer Hospital Floors
VITAS Healthcare Breaks Ground on New Inpatient Hospice Center in Florida